JGB Biopharma Consulting Inc.

JGB Biopharma Consulting Inc.

Bay Area, San Mateo, Belmont
Consulting, Payroll Services
Specialties

Excerpt

Our clients include start-up biotech companies, established pharmaceutical companies, venture capital firms, diagnostics / device and bioinformatics companies.


Company Description

Our founder, Julie Bukar, has more than 20 years BioPharma and medical device experience and has consulted in pharmaceuticals, medical devices, and diagnostics. She has consulted in project management, clinical operations, G&A, and business development. She has been an instructor for course requirements for the Berkeley Bioscience Project Management Certification. Previous positions were as Sr. Director Product Development at Rinat Neurosciences (now Pfizer); Director, Project Management at Nektar Therapeutics; Director, Corporate Development at Affymax; and project management & clinical positions at Genentech and Amgen. She holds an MBA, a B.S. from Cornell, and started her career as a Registered Dietitian.

JGB BioPharma's staff has grown to include more than a dozen recruiters and support staff. Our recruiting experts have strong technical backgrounds. We have a long work history in pharmaceutical, medical device, or diagnostics industries and a deep understanding of the drug/device and IVD development process and business needs.

We strive to understand each hiring manager's needs for each position. We match management style to candidates' work style in addition to vetting the candidates' technical qualifications. We consider and balance multiple variables that make a candidate a good fit for the job, the company, and the hiring manager.

JGB Biopharma Consulting Inc. Reviews

 
 

More Recruiters Based on Specialities

Mullings Group Search
Has practices in medical device, pharmaceutical, bio-tech and emerging technologies industries.
The Royster Group
A diversity retained search firm which aid corporations search for positions in various industries that includes he
Glocap Search LLC
We partner with select private equity funds, hedge funds, investment banks, fund of funds, consulting firms and oth